Why 5-HT2C Agonists Could Be the Next Big Epilepsy Treatment Breakthrough

Brightmindsbio14 May, 2025Health

Epilepsy treatment challenges persist despite affecting over 70 million people worldwide. What's even more concerning is that approximately one-third of these individuals—around 23 million people—suffer from drug-resistant epilepsy (DRE), which significantly increases their risk of premature death and injuries. Despite decades of research and numerous epilepsy treatment drugs available on the market, many patients continue to experience seizures that drastically impact their quality of life.